PXN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.40599995271884E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.42820000165389E-08 |
Normal-vs-Stage2 |
4.24880000071681E-08 |
Normal-vs-Stage3 |
2.084300E-03 |
Normal-vs-Stage4 |
6.406200E-02 |
Stage1-vs-Stage2 |
3.321400E-01 |
Stage1-vs-Stage3 |
3.452400E-01 |
Stage1-vs-Stage4 |
6.069000E-01 |
Stage2-vs-Stage3 |
1.900200E-01 |
Stage2-vs-Stage4 |
4.935200E-01 |
Stage3-vs-Stage4 |
9.393000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.88710047588359E-10 |
Normal-vs-AfricanAmerican |
1.84355999999219E-05 |
Normal-vs-Asian |
5.425600E-01 |
Caucasian-vs-AfricanAmerican |
2.367700E-02 |
Caucasian-vs-Asian |
3.307000E-01 |
AfricanAmerican-vs-Asian |
5.695200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.59070000504968E-08 |
Normal-vs-Female |
1.37230000030186E-07 |
Male-vs-Female |
7.672000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
8.31220000052646E-07 |
Normal-vs-Extreme_Weight |
6.99199997900024E-09 |
Normal-vs-Obese |
1.9495199999997E-05 |
Normal-vs-Extreme_Obese |
1.65751999999797E-05 |
Normal_Weight-vs-Extreme_Weight |
6.883600E-01 |
Normal_Weight-vs-Obese |
5.265200E-01 |
Normal_Weight-vs-Extreme_Obese |
4.953800E-01 |
Extreme_Weight-vs-Obese |
2.546000E-01 |
Extreme_Weight-vs-Extreme_Obese |
6.902400E-01 |
Obese-vs-Extreme_Obese |
3.098200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.033840E-01 |
Normal-vs-Age(41-60Yrs) |
1.67820000007701E-07 |
Normal-vs-Age(61-80Yrs) |
1.78401737827016E-12 |
Normal-vs-Age(81-100Yrs) |
2.32319999999842E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.528200E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.184800E-04 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.571900E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.534500E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.663800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.368600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.64210001152298E-09 |
Normal-VS-Type2 PRCC |
2.96550006773089E-10 |
Normal-VS-KIRP CIMP |
6.485000E-01 |
Normal-VS-Unclassified PRCC |
9.94989999999474E-05 |
Type1 PRCC-VS-Type2 PRCC |
5.218000E-02 |
Type1 PRCC-VS-KIRP CIMP |
2.221000E-03 |
Type1 PRCC-VS-Unclassified PRCC |
2.280000E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.761090E-03 |
Type2 PRCC-VS-Unclassified PRCC |
2.366200E-02 |
KIRP CIMP-VS-Unclassified PRCC |
4.181900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.97695243193175E-12 |
Normal-vs-N1 |
7.843100E-03 |
Normal-vs-N2 |
8.623800E-03 |
N0-vs-N1 |
4.631900E-02 |
N0-vs-N2 |
6.467800E-01 |
N1-vs-N2 |
5.450400E-01 |
|
|